Last reviewed · How we verify

NCT04655937: WAterS

Wellbeing After Stroke (WAterS): Supporting Adjustment and Wellbeing After Stroke

Completed Phase 1 Last updated 10 May 2024
What this trial tests

Phase 1 trial testing Acceptance and Commitment Therapy in Stroke in 20 participants. Completed in 1 May 2023.

Timeline
5 January 2021
Primary endpoint
15 March 2021
1 May 2023

Quick facts

Lead sponsorUniversity of Manchester
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date5 January 2021
Primary completion15 March 2021
Estimated completion1 May 2023
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Manchester

Who can join

18 and older, any sex, with Stroke or Psychological Distress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stroke survivors face a range of mental health challenges adjusting post-stroke. There is a lack of treatment options and clinical psychologist workforce to deliver support. Acceptance and Commitment Therapy (ACT) has been used successfully in clinical services to improve wellbeing. The investigators worked with stroke survivors, health care professionals and researchers to co-develop group ACT therapy, specifically for stroke survivors, to be delivered using video calling (Zoom). Staff training and supervision programmes were also developed to equip Stroke Association workforce (paraprofessionals) to deliver ACT. The current study will recruit and train up to 10 professionals with some experience of supporting stroke survivors but no experience of ACT. We then aim to recruit up to 30 stroke survivors in the community who are at least 4 months post-stroke and experiencing distress adjusting to their stroke. The investigators aimed to make everything accessible for people with mild/moderate difficulties with thinking and communicating. Recruitment took place across England, over a 6 month period. The study will test how feasible and acceptable it is to deliver the co-developed, remote ACT intervention to stroke survivors, as well as the feasibility of collecting outcomes data: 1. Participants will be invited to consent to complete online measures of well-being every 3 months for up to 12 months (taking around 20 minutes), with the option to participate in group intervention. Those who don't opt for groups will not be treated but will be followed up about their wellbeing, if they agree. 2. Those who opt to attend groups will be randomly assigned into intervention groups A, B, or C and receive the ACT intervention, involving 9 weekly sessions and homework. Data will be collected on how successfully the groups are delivered and how acceptable they are / how to improve them, through online surveys, feedback questionnaires and interviews. UPDATE May 2023: The investigators had initially intended to run an active comparator arm of social support and randomly allocated people to arms \*and\* groups. However, the design changed after the COVID-19 pandemic, meaning that the planning phases took longer than expected in order to pivot all study components to be deliverable online. \*Please see references section for our findings and publications

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Pharmacological, non-invasive brain stimulation and psychological interventions, and their combination, for treating depression after stroke.
    Allida SM, Hsieh CF, Cox KL, Patel K, et al · · 2023 · cited 11× · PMID 37417452 · DOI 10.1002/14651858.cd003437.pub5
  2. Wellbeing After Stroke (WAterS): Feasibility Testing of a Co-developed Acceptance and Commitment Therapy Intervention to Support Psychological Adjustment After Stroke.
    Patchwood E, Foote H, Vail A, Cotterill S, et al · · 2024 · cited 10× · PMID 38505946 · DOI 10.1177/02692155241239879

Verify or expand the search:

Other trials of Acceptance and Commitment Therapy

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Manchester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04655937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing